arrow_back Entities

LOQUS23 THERAPEUTICS LIMITED

active Private Limited Company
🇬🇧 GB | Incorporated 2019-03-29 | Reg. 11914774 | Data as of 2026-06-01
72110 - Research and experimental development on biotechnology

LOQUS23 THERAPEUTICS LIMITED is a private limited company registered in the United Kingdom, under 11914774, incorporated on 29 March 2019. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 7 years. Registered office address: CB21 6GP Great Abington, the United Kingdom. Directors include DR CHRISTIAN BILLY JUNG, DR CYRUS MOZAYENI, and DR FLORIAN MUELLERSHAUSEN, and 2 others. Shareholders include DEMENTIA DISCOVERY GP LP and DDF PARALLEL LLP. Associated with 4 related entities, including DDF PARALLEL LLP, NRG THERAPEUTICS LTD, and AMPHISTA THERAPEUTICS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.

bookmark_add Save this entity to a watchlist · Get alerts on changes · API access
Sign up free

Official Identifiers

REGISTRATION NUMBER 11914774

Registered Address

SUITE 7 MCCLINTOCK BUILDING
GRANTA PARK
CAMBRIDGESHIRE
CB21 6GP GREAT ABINGTON
the United Kingdom

Signal Intelligence

verified

No sanctions, PEP status, or adverse risk signals are currently on record for this entity.

Key Management & Controllers

DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
25-50% SHAREHOLDER
🇬🇧 DDF PARALLEL LLP
25-50% SHAREHOLDER

Associated Entities

Companies sharing one or more directors or officers with this entity.

Source Records (1)

companieshouse 11914774 2026-06-01 open_in_new
Save entities, get alerts on changes, API access Sign up free